Austin Koukol

Affiliations

Actuate Therapeutics, United States.

ORCID: 0009-0003-1446-7920

Publications (1)

Phase 1 study of Elraglusib (9-ING-41), a glycogen synthase kinase-3b inhibitor, as monotherapy or combined with chemotherapy in patients with advanced malignancies.

Clinical cancer research : an official journal of the American Association for Cancer Research

Avec: Benedito A Carneiro , Ludimila Cavalcante , Devalingam Mahalingam , Anwaar Saeed , Howard Safran , Wen Wee Ma , Andrew L Coveler , Steven Powell , Bruno Bastos , Elizabeth Davis , Vaibhav Sahai , William Mikrut , James Longstreth , Sheri Smith , Taylor Weiskittel , Hu Li , Brittany A Borden , R Donald Harvey , Solmaz Sahebjam , Andres Cervantes , Austin Koukol , Andrew P Mazar , Neeltje Steeghs , Razelle Kurzrock , Francis J Giles , Pamela Munster

Réseau de co-auteurs

Benedito A Carneiro 1 collaboration

Ludimila Cavalcante 1 collaboration

Devalingam Mahalingam 1 collaboration

Anwaar Saeed 1 collaboration

Howard Safran 1 collaboration

Wen Wee Ma 1 collaboration

Andrew L Coveler 1 collaboration

Steven Powell 1 collaboration

Bruno Bastos 1 collaboration

Elizabeth Davis 1 collaboration

Vaibhav Sahai 1 collaboration

William Mikrut 1 collaboration

James Longstreth 1 collaboration

Sheri Smith 1 collaboration

Taylor Weiskittel 1 collaboration

Hu Li 1 collaboration

Brittany A Borden 1 collaboration

R Donald Harvey 1 collaboration

Solmaz Sahebjam 1 collaboration

Andres Cervantes 1 collaboration

Andrew P Mazar 1 collaboration

Neeltje Steeghs 1 collaboration

Razelle Kurzrock 1 collaboration

Francis J Giles 1 collaboration

Pamela Munster 1 collaboration